HEMOPOC
LIVE

Serial Number

79289214

Owner

Helixgen (Guangzhou) Co., Ltd.

Attorney

Zhi Dong

Filing Date

May 7, 2020

Add to watchlist:

No watchlists yet
View on USPTO

HEMOPOC Trademark

Serial Number: 79289214 • Registration: 6366865

HEMOPOC is a trademark filed by Helixgen (Guangzhou) Co., Ltd. on May 7, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Helixgen (Guangzhou) Co., Ltd.

Unit 901, C2 No. 182 Kexue Ave.

Entity Type: 99

Trademark Details

Filing Date

May 7, 2020

Registration Date

June 1, 2021

Published for Opposition

March 16, 2021

Goods & Services

Apparatus for use in medical analysis, namely, apparatus for analyzing blood, body fluid and excrement, and medical diagnostic apparatus for analyzing and measuring tumour cells in the blood, body fluid and excrement samples; testing apparatus for medical purposes, namely, testing apparatus for blood, body fluid and excrement, and medical diagnostic apparatus for testing DNA and RNA samples, tumour cells testing apparatus for medical use; diagnostic apparatus for medical purposes, namely, diagnostic apparatus for the detection and screening of tumors, and medical diagnostic apparatus for testing tumor cells and DNA; blood testing apparatus; hemocytometers; sphygmomanometers; respirators for artificial respiration; apparatus for artificial respiration; dropper bottles for administering medication, sold empty; medical apparatus and instruments, namely, medical apparatus and instruments for monitoring characteristic of blood, body fluid and excrement, medical apparatus and instruments for treating cancers, medical apparatus and instruments for preventing or reversing cancers, medical apparatus and instruments for measuring and displaying tumour cells in the blood, body fluid and excrement samples

Diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; reagent paper for medical or veterinary purposes; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for the treatment of colorectal diseases and colorectal cancer; biological preparations for medical purposes for the treatment of colorectal diseases and colorectal cancer; bacteriological preparations for medical and veterinary use; chemical preparations for pharmaceutical purposes for the treatment of colorectal diseases and colorectal cancer; enzyme preparations for medical purposes; nutritive substances for microorganisms for medical purposes

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 1, 2026 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 25, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 23, 2021 FICS
FINAL DISPOSITION PROCESSED
Sep 23, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 1, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 1, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 16, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 16, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Mar 15, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 24, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 24, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 24, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 11, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 11, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 11, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 11, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 11, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 10, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 10, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 10, 2021 TROA
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Jan 20, 2021 LOPR
LETTER OF PROTEST EVIDENCE FORWARDED
Jan 19, 2021 LOPT
REFUSAL PROCESSED BY IB
Sep 27, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 6, 2020 RFCS
REFUSAL PROCESSED BY MPU
Sep 1, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 4, 2020 RFCR
NON-FINAL ACTION WRITTEN
Aug 3, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 3, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 14, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 10, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 9, 2020 REPR